These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8598612)

  • 1. Cost-effectiveness of stroke prophylaxis for nonvalvular atrial fibrillation.
    Kan BD; Katz DA
    JAMA; 1996 Mar; 275(12):909; author reply 910. PubMed ID: 8598612
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation.
    Gage BF; Cardinalli AB; Albers GW; Owens DK
    JAMA; 1995 Dec; 274(23):1839-45. PubMed ID: 7500532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective.
    Athanasakis K; Boubouchairopoulou N; Karampli E; Tarantilis F; Savvari P; Bilitou A; Kyriopoulos J
    Am J Cardiovasc Drugs; 2017 Apr; 17(2):123-133. PubMed ID: 27882517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis.
    Quinn RR; Naimark DM; Oliver MJ; Bayoumi AM
    Am J Kidney Dis; 2007 Sep; 50(3):421-32. PubMed ID: 17720521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation.
    Morrison CM; Gainsborough N; Rajkumar C
    Age Ageing; 2007 Mar; 36(2):117-9. PubMed ID: 17255089
    [No Abstract]   [Full Text] [Related]  

  • 6. Warfarin, aspirin, and atrial fibrillation.
    Harv Heart Lett; 1998 Aug; 8(12):4-6. PubMed ID: 9713234
    [No Abstract]   [Full Text] [Related]  

  • 7. Warfarin sodium or aspirin therapy to prevent stroke in nonrheumatic atrial fibrillation. Answered and unanswered questions.
    Stratton JR
    West J Med; 1995 Aug; 163(2):177-9. PubMed ID: 7571577
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of different strategies for stroke prevention in patients with atrial fibrillation in a health resource-limited setting.
    Wu B; Kun L; Liu X; He B
    Cardiovasc Drugs Ther; 2014 Feb; 28(1):87-98. PubMed ID: 24048510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacing aspirin and warfarin for secondary stroke prevention: is it worth the costs?
    Hankey GJ
    Curr Opin Neurol; 2010 Feb; 23(1):65-72. PubMed ID: 19949330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic therapy in atrial fibrillation.
    Turpie AG; Connolly SJ
    Can Fam Physician; 1996 Jul; 42():1341-5. PubMed ID: 8754703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention of stroke.
    Martinez-Riera A; Santolaria-Fernandez F; Gonzalez-Reimers E
    N Engl J Med; 1996 Apr; 334(17):1138; author reply 1139. PubMed ID: 8598884
    [No Abstract]   [Full Text] [Related]  

  • 12. Warfarin vs aspirin and AFASAK 2.
    Bloom JM
    Arch Intern Med; 1999 May; 159(9):1010-1. PubMed ID: 10326947
    [No Abstract]   [Full Text] [Related]  

  • 13. Stroke prevention in nonvalvular atrial fibrillation.
    Albers GW; Atwood JE; Hirsh J; Sherman DG; Hughes RA; Connolly SJ
    Ann Intern Med; 1991 Nov; 115(9):727-36. PubMed ID: 1834004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and prevention of stroke.
    Morocutti C; Coccheri S
    Lancet; 1994 Jan; 343(8891):234. PubMed ID: 7904685
    [No Abstract]   [Full Text] [Related]  

  • 15. [Atrial fibrillation due to non-valvular causes: indications for antithrombotic therapy].
    Codinach Huix P
    Med Clin (Barc); 1996 Apr; 106(15):586-9. PubMed ID: 8656759
    [No Abstract]   [Full Text] [Related]  

  • 16. Additional risk factors in atrial fibrillation patients not receiving warfarin.
    Wensley S; Keir S; Caine S; Mac Mahon M
    Age Ageing; 1999 Jul; 28(4):355-7. PubMed ID: 10459787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable.
    Coleman CI; Straznitskas AD; Sobieraj DM; Kluger J; Anglade MW
    Am J Cardiol; 2012 Apr; 109(7):1020-5. PubMed ID: 22221944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of the month. Prevention of cerebral vascular accidents in patients with atrial fibrillation].
    Scheen AJ
    Rev Med Liege; 1999 Jun; 54(6):561-3. PubMed ID: 10446529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation and stroke prevention in the community.
    O'Connell JE; Gray CS
    Age Ageing; 1996 Jul; 25(4):307-9. PubMed ID: 8831876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation.
    Catherwood E; Fitzpatrick WD; Greenberg ML; Holzberger PT; Malenka DJ; Gerling BR; Birkmeyer JD
    Ann Intern Med; 1999 Apr; 130(8):625-36. PubMed ID: 10215558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.